Form 4 for RCEL AVITA Medical, Inc.

Accepted 2021-12-27 00:00:00 ET · period of report 2021-12-22 · accession 0001209191-21-071250 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2021-12-27	2021-12-22	RCEL	REED JAN STERN	Dir	A - Grant	—	+13.0K	13.0K	New	—
DM	2021-12-27	2021-12-22	RCEL	REED JAN STERN	Dir	A - Grant	$0.00	+7,475	4,925	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-12-22	A	A	8,675	—	8,675	D	—	—	(F1) Represents an award of Restricted Stock Units ("RSUs"), each representing a contingent right to be issued one share of Common Stock, that are subject to time-based vesting criteria. These RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date. (F2) Includes unvested RSUs.
2	Common	Common Stock	2021-12-22	A	A	4,350	—	13,025	D	—	—	(F3) Represents an award of RSUs that vest on the date 12 months following the grant date. (F2) Includes unvested RSUs.
3	Derivative	Stock Options (Right to Buy)	2021-12-22	A	A	2,550	$0.00	2,550	D	$12.18 · — to 2031-12-22	2,550 Common Stock	(F5) These Stock Options vest on the date 12 months following the grant date.
4	Derivative	Stock Options (Right to Buy)	2021-12-22	A	A	4,925	$0.00	4,925	D	$12.18 · — to 2031-12-22	4,925 Common Stock	(F4) These Stock Options vest in three equal annual installments on the first, second and third anniversaries of the grant date.